vTv Therapeutics (VTVT) Treasury Shares (2014 - 2015)
vTv Therapeutics' (VTVT) quarterly Treasury Shares came in at $1.2 billion in Q2 2015, up 4.24% quarter-over-quarter from $1.1 billion in Q4 2014.
Analysis
vTv Therapeutics (VTVT) Treasury Shares (2014 - 2015) Analysis & Trends
vTv Therapeutics has disclosed Treasury Shares across 2 years of filings, most recently posting $1.2 billion for Q2 2015.
- In Q2 2015, Treasury Shares changed N/A year-over-year to $1.2 billion; the TTM figure through Jun 2015 stood at $1.2 billion (changed N/A YoY), while the FY2014 annual figure was $1.1 billion, changed N/A from the prior year.
- Treasury Shares came in at $1.2 billion for Q2 2015 at vTv Therapeutics, up from $1.1 billion in the prior quarter.
- In the past five years, Treasury Shares ranged from a high of $1.2 billion in Q2 2015 to a low of $1.1 billion in Q4 2014.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 663.08 Bn | 642.33 Bn | 17.26 Bn | 711.62 Mn |
| 2 | AbbVie | 453.04 Bn | 446.51 Bn | 12.70 Bn | 10.62 Bn |
| 3 | Merck | 370.87 Bn | 363.78 Bn | 12.21 Bn | 1.11 Bn |
| 4 | Novartis Ag | 305.29 Bn | 298.00 Bn | 11.24 Bn | -49.00 Mn |
| 5 | Pfizer | 162.10 Bn | 150.70 Bn | 10.94 Bn | 115.19 Bn |
| 6 | Sanofi | 53.95 Bn | 46.98 Bn | 10.79 Bn | - |
| 7 | Revolution Medicines | 45.00 Bn | 45.00 Bn | - | - |
| 8 | BeOne Medicines | 40.49 Bn | 35.39 Bn | 1.53 Bn | - |
| 9 | Incyte | 25.47 Bn | 20.94 Bn | 1.57 Bn | - |
| 10 | vTv Therapeutics | 413.85 Mn | 413.85 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2015 | 1.19 Bn |
| Jun 30, 2015 | 1.19 Bn |
| Dec 31, 2014 | 1.15 Bn |
| Dec 31, 2014 | 1.15 Bn |